American National Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.4M Sell
77,067
-2,059
-3% -$443K 1.66% 15
2026
Q1
$17.2M Sell
79,126
-119
-0.2% -$26.4K 1.64% 17
2025
Q4
$18.1M Buy
79,245
+443
+0.6% +$101K 1.71% 15
2025
Q3
$18.2M Sell
78,802
-1,863
-2% -$379K 1.8% 12
2025
Q2
$15M Buy
80,665
+2,320
+3% +$431K 1.53% 15
2025
Q1
$16.4M Sell
78,345
-3,936
-5% -$765K 1.82% 15
2024
Q4
$14.6M Buy
82,281
+17,545
+27% +$3.23M 1.63% 16
2024
Q3
$12.8M Sell
64,736
-5,485
-8% -$1.02M 1.51% 17
2024
Q2
$12M Buy
70,221
+9,013
+15% +$1.49M 1.5% 16
2024
Q1
$11.1M Buy
61,208
+1,816
+3% +$313K 1.48% 20
2023
Q4
$9.2M Buy
59,392
+2,695
+5% +$393K 1.45% 19
2023
Q3
$8.45M Buy
56,697
+2,467
+5% +$362K 1.44% 20
2023
Q2
$7.31M Buy
54,230
+5,902
+12% +$865K 1.23% 25
2023
Q1
$7.7M Buy
48,328
+2,319
+5% +$355K 1.42% 22
2022
Q4
$7.44M Sell
46,009
-563
-1% -$86.3K 1.53% 20
2022
Q3
$6.25M Sell
46,572
-806
-2% -$116K 1.49% 23
2022
Q2
$7.26M Sell
47,378
-11,335
-19% -$1.73M 1.73% 19
2022
Q1
$9.52M Buy
58,713
+193
+0.3% +$28K 1.89% 17
2021
Q4
$7.92M Sell
58,520
-1,436
-2% -$170K 1.55% 22
2021
Q3
$6.47M Buy
59,956
+8,360
+16% +$955K 1.43% 27
2021
Q2
$5.81M Sell
51,596
-4,183
-7% -$471K 1.24% 34
2021
Q1
$6.04M Buy
55,779
+15,068
+37% +$1.61M 1.42% 29
2020
Q4
$4.36M Buy
40,711
+38,236
+1,545% +$3.67M 1.13% 38
2020
Q3
$217K Buy
2,475
+580
+31% +$54.6K 0.06% 87
2020
Q2
$186K Buy
1,895
+695
+58% +$61.2K 0.06% 91
2020
Q1
$91K Sell
1,200
-4,034
-77% -$344K 0.04% 109
2019
Q4
$463K Sell
5,234
-1,741
-25% -$145K 0.14% 76
2019
Q3
$528K Buy
6,975
+52
+0.8% +$3.56K 0.16% 72
2019
Q2
$503K Buy
6,923
+45
+0.7% +$3.54K 0.16% 75
2019
Q1
$554K Buy
6,878
+2,327
+51% +$190K 0.18% 80
2018
Q4
$420K Sell
4,551
-13
-0.3% -$1.14K 0.15% 75
2018
Q3
$432K Sell
4,564
-21
-0.5% -$1.99K 0.12% 90
2018
Q2
$425K Buy
4,585
+14
+0.3% +$1.37K 0.12% 97
2018
Q1
$433K Buy
4,571
+813
+22% +$89.3K 0.12% 92
2017
Q4
$363K Sell
3,758
-4,825
-56% -$455K 0.1% 102
2017
Q3
$763K Buy
8,583
+4,590
+115% +$349K 0.23% 76
2017
Q2
$290K Buy
3,993
+1,522
+62% +$102K 0.09% 95
2017
Q1
$161K Buy
2,471
+299
+14% +$18.8K 0.05% 111
2016
Q4
$136K Buy
2,172
+1,657
+322% +$101K 0.04% 116
2016
Q3
$32K Hold
515
0.01% 147
2016
Q2
$32K Buy
+515
New +$31.4K 0.01% 146
2016
Q1
Sell
-1
Closed 203
2015
Q4
$0 Sell
1
-64,741
-100% -$3.73M ﹤0.01% 230
2015
Q3
$3.52M Hold
64,742
1.5% 23
2015
Q2
$4.35M Sell
64,742
-1,735
-3% -$113K 1.74% 22
2015
Q1
$3.89M Sell
66,477
-3,437
-5% -$208K 1.51% 27
2014
Q4
$4.58M Sell
69,914
-813
-1% -$51.3K 1.75% 22
2014
Q3
$4.08M Sell
70,727
-89
-0.1% -$4.94K 1.58% 24
2014
Q2
$4M Sell
70,816
-1,067
-1% -$56K 1.5% 28
2014
Q1
$3.69M Sell
71,883
-178
-0.2% -$9K 1.48% 31
2013
Q4
$3.81M Sell
72,061
-1,260
-2% -$61.9K 1.52% 30
2013
Q3
$3.28M Sell
73,321
-102
-0.1% -$4.52K 1.39% 30
2013
Q2
$3.04M Buy
+73,423
New +$3.21M 1.35% 30

Other funds holding ABBV

American National Bank & Trust's ABBV Position: Q2 2026 in Review

American National Bank & Trust reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $443K and leaving 77,067 shares worth $19.4M. The position accounts for 1.66% of the portfolio, ranked #15.

American National Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 1,561 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • American National Bank & Trust held 77,067 shares of AbbVie worth $19.4M as of Q2 2026.
  • American National Bank & Trust sold 2,059 AbbVie shares in Q2 2026, an estimated $443K.
  • AbbVie made up 1.66% of American National Bank & Trust's portfolio in Q2 2026, its #15 holding.
  • American National Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 1,561 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.